Page last updated: 2024-10-24

bupivacaine and Nearsightedness

bupivacaine has been researched along with Nearsightedness in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research Excerpts

ExcerptRelevanceReference
"We report the results of injection of bupivacaine (BUP) and botulinum toxin (BT) into agonist and antagonist muscles, respectively, to treat horizontal strabismus."7.75Treating strabismus by injecting the agonist muscle with bupivacaine and the antagonist with botulinum toxin. ( Miller, JM; Scott, AB; Shieh, KR, 2009)
"We report the results of injection of bupivacaine (BUP) and botulinum toxin (BT) into agonist and antagonist muscles, respectively, to treat horizontal strabismus."3.75Treating strabismus by injecting the agonist muscle with bupivacaine and the antagonist with botulinum toxin. ( Miller, JM; Scott, AB; Shieh, KR, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scott, AB1
Miller, JM1
Shieh, KR1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Bupivacaine Injection of Eye Muscles to Treat Strabismus[NCT01616108]Phase 2/Phase 3120 participants (Anticipated)Interventional2012-04-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for bupivacaine and Nearsightedness

ArticleYear
Treating strabismus by injecting the agonist muscle with bupivacaine and the antagonist with botulinum toxin.
    Transactions of the American Ophthalmological Society, 2009, Volume: 107

    Topics: Adult; Anti-Dyskinesia Agents; Atrophy; Botulinum Toxins; Bupivacaine; Dose-Response Relationship, D

2009